Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.
about
Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.Inflammation and oxidative stress in obesity-related glomerulopathyRenal podocyte injury in a rat model of type 2 diabetes is prevented by metformin.Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.The spontaneously diabetic torii rat: an animal model of nonobese type 2 diabetes with severe diabetic complications.Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.Obstructive sleep apnea and diabetic nephropathy: a cohort study.Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.Oxidative cell injury as a predictor of endometriosis progression.Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.Modulation of NADPH oxidase activity by known uraemic retention solutes.Anti-oxidative Effect of the β-blocker Carvedilol on Diabetic Nephropathy in Non-obese Type 2 Diabetic Rats.The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus.Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
P2860
Q34566577-F73B0981-697B-4BA3-9A79-4D80A2F8CD1AQ35147432-EE1F3248-093B-4AED-80D7-365A74DF116CQ35904102-FC01A362-F376-4452-BD2C-90A3E3F40895Q36302667-CEEB11BE-83C4-4009-B000-8190E736669DQ36518342-8C80C3DE-EA2E-4313-A030-EFFF221BF924Q36825739-92C37405-2F75-4B9B-978F-6DB1E21B519CQ37084883-1C2FFE31-60F0-4D7F-B55A-11DC151FDCF6Q37278124-67B56D19-46D8-490F-BB82-E5109B66EFEAQ39202218-9F6203AA-48A0-4DF2-8650-2054D0B6F8FBQ39607056-A3B983D4-F149-4D0F-A573-B412EF3F1EB2Q42043023-284EF308-64C9-41A9-A15C-47D071F7365EQ42154496-F9E247C1-E357-4B71-A65F-0F3A46E2DCC7Q43467792-45EFD7A8-078C-4228-B83E-9AE591647129Q43556907-8234E12C-F187-411A-89D8-1899900B5BE3Q43996148-03C5C044-27F8-499F-AAD6-9ED7935677BBQ44047436-6BFE15E2-A7F2-4432-96C6-A9C986B3745AQ46864424-C1B2B977-7C95-4515-A26D-2B51B8D86092Q50045877-F5B64D45-5FC1-413A-882C-4B7B11BF23C7Q52146506-2D6C60D0-8DDE-4E7A-A7F8-1513FFFEB6BDQ55254641-8E65CDFD-4F4F-421B-A585-32C1E1F6332D
P2860
Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@en
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@nl
type
label
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@en
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@nl
prefLabel
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@en
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@nl
P2093
P50
P356
P1476
Oxidative and nitrosative stre ...... ephropathy in type 2 diabetes.
@en
P2093
Hideki Fujii
Keiji Kono
Masafumi Fukagawa
Masami Shinohara
Riko Kitazawa
Shunsuke Goto
Yasuhiro Hamada
P304
P356
10.1159/000297290
P577
2010-03-12T00:00:00Z